KLAS Contact
Contact KLAS
Contact KLAS
2023 BEST IN KLAS
Preferences
Related Series
Related Segments
Related Articles
European Digital Pathology 2021
Adoption Grows for Primary Diagnosis
Author
Eder Lagemann
Author
Jonathan Christensen
Author
Sidney Tate
Current Time Inside Cache Tag Helper: 6/6/2023 9:19:54 PM and Model.reportId = 1764
Use of digital pathology for primary diagnosis† has recently seen a rapid increase in both interest and adoption, thanks to benefits like improved efficiency and remote reading/telepathology capabilities (see KLAS’ 2019 report). The COVID-19 pandemic has spurred even greater consideration of remote-reading options, and some organizations are looking to digital pathology to mitigate anticipated pathologist shortages in the future. Overall, Europe has seen the greatest adoption of digital pathology. For this report, KLAS interviewed pathology groups across 15 European countries who are live with digital pathology for primary diagnosis. The following pages share performance insights on Philips, Sectra, and Tribun Health—the market leaders in considerations and live customers for digital pathology image management systems (IMS).if you don't have a login, getting started is easy.
† Use of digital pathology for research purposes is much more widespread and is not the focus of this report. Most primary diagnosis done today is for histology cases; cytology use cases are currently much less common.
Key Findings:
- Digital Pathology Growing Rapidly in Europe; Philips, Sectra, Tribun Health Lead in Adoption
- Tribun Health Delivers Strong, Consistent Customer Experience in French-Speaking Countries
- Sectra’s Well-Developed Solution Leads to Rapid Growth
- Philips Delivers Easy-to-Use, All-in-One Solution; Customers Want Faster Development
- Scanners from Hamamatsu Used Most Frequently, Followed by Leica Biosystems & 3DHISTECH
Writer
Amanda Wind Smith
Designer
Natalie Jamison
Project Manager
Jill Knapp
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.